Ben-Mahmoud Afif, Jun Kyung Ran, Gupta Vijay, Shastri Pinang, de la Fuente Alberto, Park Yongsoo, Shin Kyung Chul, Kim Chong Ae, da Cruz Aparecido Divino, Pinto Irene Plaza, Minasi Lysa Bernardes, Silva da Cruz Alex, Faivre Laurence, Callier Patrick, Racine Caroline, Layman Lawrence C, Kong Il-Keun, Kim Cheol-Hee, Kim Woo-Yang, Kim Hyung-Goo
Neurological Disorders Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
Department of Laboratory Medicine, Inje University Haeundae Paik Hospital, Busan, South Korea.
Front Mol Neurosci. 2022 Oct 6;15:979061. doi: 10.3389/fnmol.2022.979061. eCollection 2022.
Genome-wide chromosomal microarray is extensively used to detect copy number variations (CNVs), which can diagnose microdeletion and microduplication syndromes. These small unbalanced chromosomal structural rearrangements ranging from 1 kb to 10 Mb comprise up to 15% of human mutations leading to monogenic or contiguous genomic disorders. Albeit rare, CNVs at 1p13.3 cause a variety of neurodevelopmental disorders (NDDs) including development delay (DD), intellectual disability (ID), autism, epilepsy, and craniofacial anomalies (CFA). Most of the 1p13.3 CNV cases reported in the pre-microarray era encompassed a large number of genes and lacked the demarcating genomic coordinates, hampering the discovery of positional candidate genes within the boundaries. In this study, we present four subjects with 1p13.3 microdeletions displaying DD, ID, autism, epilepsy, and CFA. comparative genomic mapping with three previously reported subjects with CNVs and 22 unreported DECIPHER CNV cases has resulted in the identification of four different sub-genomic loci harboring five positional candidate genes for DD, ID, and CFA at 1p13.3. Most of these genes have pathogenic variants reported, and their interacting genes are involved in NDDs. RT-qPCR in various human tissues revealed a high expression pattern in the brain and fetal brain, supporting their functional roles in NDDs. Interrogation of variant databases and interacting protein partners led to the identification of another set of 11 potential candidate genes, which might have been dysregulated by the position effect of these CNVs at 1p13.3. Our studies define 1p13.3 as a genomic region harboring 16 NDD candidate genes and underscore the critical roles of small CNVs in comparative genomic mapping for disease gene discovery. Our candidate genes will help accelerate the isolation of pathogenic heterozygous variants from exome/genome sequencing (ES/GS) databases.
全基因组染色体微阵列被广泛用于检测拷贝数变异(CNV),其可诊断微缺失和微重复综合征。这些大小从1 kb到10 Mb的小的不平衡染色体结构重排占导致单基因或连续性基因组疾病的人类突变的15%。尽管罕见,但1p13.3处的CNV会导致多种神经发育障碍(NDD),包括发育迟缓(DD)、智力残疾(ID)、自闭症、癫痫和颅面畸形(CFA)。在微阵列时代之前报道的大多数1p13.3 CNV病例包含大量基因且缺乏明确的基因组坐标,这阻碍了在边界内发现定位候选基因。在本研究中,我们报告了4例患有1p13.3微缺失的患者,他们表现出DD、ID、自闭症、癫痫和CFA。通过与3例先前报道的患有CNV的患者以及22例未报道的DECIPHER CNV病例进行比较基因组图谱分析,已鉴定出4个不同的亚基因组位点,这些位点包含1p13.3处与DD、ID和CFA相关的5个定位候选基因。这些基因中的大多数都有报道的致病变异,并且它们的相互作用基因与NDD有关。在各种人体组织中进行的RT-qPCR显示,这些基因在大脑和胎儿大脑中呈高表达模式,支持它们在NDD中的功能作用。对变异数据库和相互作用蛋白伙伴的研究导致鉴定出另一组11个潜在候选基因,这些基因可能因1p13.3处这些CNV的位置效应而失调。我们的研究将1p13.3定义为一个包含16个NDD候选基因的基因组区域,并强调了小CNV在疾病基因发现的比较基因组图谱分析中的关键作用。我们的候选基因将有助于加速从外显子组/基因组测序(ES/GS)数据库中分离致病性杂合变异。